Single-cell transcriptome sequencing reveals potential novel combination of biomarkers for antibody-based cancer therapeutics in hepatocellular carcinoma

Background: Antibody-based cancer therapeutics is developing rapidly in recent years for its advantages in precisely targeting the tumor cells. However, tumor-specific cell surface antigens are still lacking, and the heterogeneity of tumor mass greatly impeded the development of effective drugs. Met...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Hong, Yuan, Jun, Gong, Yuan-Feng, Zhang, Cheng-Yang, Liu, Ming, Luo, Su-Xia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515615/
https://www.ncbi.nlm.nih.gov/pubmed/36186483
http://dx.doi.org/10.3389/fgene.2022.928256

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515615/
https://www.ncbi.nlm.nih.gov/pubmed/36186483
http://dx.doi.org/10.3389/fgene.2022.928256

Ejemplares similares